Medicare Enrolled
Dr. Ashish Trivedi, MD
Optician · Auburn, WA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Trivedi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Trivedi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Trivedi
Dr. Ashish Trivedi is an optician specialist in Auburn, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Trivedi performed 9,080 Medicare services across 1,992 unique beneficiaries.
Between the years covered by Open Payments, Dr. Trivedi received a total of $133,888 from 82 pharmaceutical and/or device companies across 1459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Trivedi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 7% volume in WA
$133,888 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,080
Medicare services
Top 7% in WA for optician
1,992
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~454 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
6,700 | $5 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
557 | $97 | $250 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
265 | $70 | $175 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
240 | $104 | $213 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
239 | $35 | $110 |
| Additional 30 minutes of psychological or neuropsychological testing This code represents an additional 30-minute increment for administering psychological or neuropsychological tests. It is used to bill for time beyond the initial testing period. |
238 | $32 | $110 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
179 | $86 | $300 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
170 | $403 | $950 |
| New patient office visit, complex (60-74 min) | 115 | $170 | $475 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
111 | $44 | $175 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
109 | $127 | $351 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
55 | $190 | $600 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
35 | $153 | $500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
35 | $146 | $285 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
17 | $113 | $400 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
15 | $255 | $900 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$133,888
Total received (2018-2024)
Avg $19,127/year across 7 years
Top 3% in WA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
1,459
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$71,976 (53.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$40,972 (30.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,940 (15.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,079
2023
$13,861
2022
$10,729
2021
$13,191
2020
$35,686
2019
$35,635
2018
$20,706
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Scientific Affairs, LLC
$869
EMD Serono, Inc.
$574
Lilly USA, LLC
$349
ABBVIE INC.
$298
Lundbeck LLC
$183
UCB, Inc.
$168
Eisai Inc.
$155
Biogen, Inc.
$147
Merz Pharmaceuticals, LLC
$121
Takeda Pharmaceuticals U.S.A., Inc.
$114
ACADIA Pharmaceuticals Inc
$104
PFIZER INC.
$89
Teva Pharmaceuticals USA, Inc.
$87
Celgene Corporation
$70
Genentech USA, Inc.
$66
ARGENX US, INC.
$64
Alexion Pharmaceuticals, Inc.
$62
TG Therapeutics, Inc.
$57
CSL Behring
$53
Otsuka America Pharmaceutical, Inc.
$52
GENZYME CORPORATION
$51
SK Life Science, Inc.
$48
Amneal Pharmaceuticals LLC
$41
Azurity Pharmaceuticals, Inc.
$35
Novartis Pharmaceuticals Corporation
$34
Vanda Pharmaceuticals Inc.
$27
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
Ipsen Biopharmaceuticals, Inc
$21
Nevro Corp.
$19
BANNER LIFE SCIENCES, LLC
$19
Octapharma USA, Inc.
$17
Cala Health, Inc.
$16
Neurocrine Biosciences, Inc.
$16
ANI Pharmaceuticals, Inc.
$15
Neurelis, Inc.
$14
Top 3 companies account for 43.9% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$48,753
Celgene Corporation
$20,229
Neurocrine Biosciences, Inc.
$17,488
EMD Serono, Inc.
$12,788
SK Life Science, Inc.
$6,271
E.R. Squibb & Sons, L.L.C.
$5,501
Neurelis, Inc.
$4,032
Biogen, Inc.
$2,244
Teva Pharmaceuticals USA, Inc.
$1,458
Kyowa Kirin, Inc.
$1,393
Lundbeck LLC
$1,066
Novartis Pharmaceuticals Corporation
$920
GENZYME CORPORATION
$898
Janssen Scientific Affairs, LLC
$869
Alexion Pharmaceuticals, Inc.
$744
ACADIA Pharmaceuticals Inc
$690
Acorda Therapeutics, Inc
$565
Amgen Inc.
$530
Genentech USA, Inc.
$465
Amneal Pharmaceuticals LLC
$442
AbbVie Inc.
$407
CSL Behring
$402
ABBVIE INC.
$388
UCB, Inc.
$370
NOVARTIS PHARMACEUTICALS CORPORATION
$367
Supernus Pharmaceuticals, Inc.
$355
Janssen Pharmaceuticals, Inc
$254
Avanir Pharmaceuticals, Inc.
$252
PFIZER INC.
$229
Eisai Inc.
$227
Biohaven Pharmaceuticals, Inc.
$210
Merz Pharmaceuticals, LLC
$179
Otsuka America Pharmaceutical, Inc.
$172
US WorldMeds, LLC
$170
Bausch Health US, LLC
$169
Vertical Pharmaceuticals, LLC
$167
Sumitomo Pharma America, Inc.
$164
Boston Scientific Corporation
$163
BOSTON SCIENTIFIC CORPORATION
$154
Takeda Pharmaceuticals U.S.A., Inc.
$149
ARGENX US, INC.
$123
Allergan, Inc.
$111
Eli Lilly and Company
$87
BANNER LIFE SCIENCES, LLC
$82
Biohaven Pharmaceutical Holding Company Ltd.
$74
Ipsen Biopharmaceuticals, Inc
$65
TG Therapeutics, Inc.
$57
ARBOR PHARMACEUTICALS, INC.
$54
Arbor Pharmaceuticals, Inc.
$50
Azurity Pharmaceuticals, Inc.
$49
CATALYST PHARMACEUTICALS, INC.
$48
Strongbridge US INC.
$45
Alnylam Pharmaceuticals Inc.
$44
EISAI INC.
$43
Octapharma USA, Inc.
$42
GE HEALTHCARE
$41
Bayer HealthCare Pharmaceuticals Inc.
$38
Mallinckrodt Enterprises LLC
$36
Avion Pharmaceuticals
$36
TG THERAPEUTICS, INC.
$34
Impax Laboratories, Inc.
$32
MERZ NORTH AMERICA, INC.
$29
Zogenix Inc.
$28
Vanda Pharmaceuticals Inc.
$27
GE HealthCare
$25
Amylyx Pharmaceuticals, Inc.
$24
UPSHER-SMITH LABORATORIES LLC
$21
Otsuka Pharmaceutical Development & Commercialization, Inc.
$21
Nevro Corp.
$19
Catalyst Pharmaceuticals, Inc.
$19
Grifols USA, LLC
$19
Axsome Therapeutics, Inc.
$18
MDD US Operations, LLC
$17
Zyla Life Sciences
$17
Cala Health, Inc.
$16
ASSERTIO THERAPEUTICS, Inc.
$16
Akcea Therapeutics, Inc.
$16
SANOFI-AVENTIS U.S. LLC
$16
Assertio Therapeutics, Inc.
$16
ANI Pharmaceuticals, Inc.
$15
Mallinckrodt Hospital Products Inc.
$12
Purdue Pharma L.P.
$11
Top 3 companies account for 64.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Betaseron · Briviact · CALA KIQ · COMIRNATY · COPAXONE · Cambia · DISEASE STATE · DIVIGEL · DYSPORT · Dysport · EMGALITY · Edarbi · Enspryng · FIRDAPSE · FORTEO · Fintepla · Fycompa · GENERAL DBS · GENERAL DBS · GILENYA · Gamunex-C · Gralise · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LEQEMBI · LUMIZYME · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ozanimod · PANZYGA · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RELYVRIO · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SYMPROIC · Senza · Soliris · Sunosi · TEGSEDI · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VUMERITY · VYALEV · VYEPTI · VYVGART HYTRULO · Vimpat · WELLBUTRIN · XCOPRI · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for optician in WA.
Geographic Context
Opticians within 10 mi
995
Per 100K population
44.0
County median income
$122,148
Nearest hospital
MULTICARE AUBURN MEDICAL CENTER
2.3 mi
2.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Trivedi is a clinical cardiology specialist, with above-average Medicare volume (top 7% in WA), with consulting-driven industry engagement in the top 3% of WA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Trivedi experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Trivedi performed 6,700 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Trivedi receive payments from pharmaceutical companies?
Yes. Dr. Trivedi received a total of $133,888 from 82 companies across 1,459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Trivedi's costs compare to other opticians in Auburn?
Dr. Trivedi's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Trivedi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Auburn
Browse opticians in Auburn ranked by procedure volume and transparency data.
Highest volume
Top Opticians in WA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in WA
Which WA opticians receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Neurocrine Biosciences, Inc. Payments to Doctors
See all physicians who received payments from Neurocrine Biosciences, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology